Literature DB >> 13409596

Four years' experience of melarsen oxide/BAL in the treatment of late-stage Rhodesian sleeping sickness.

F I APTED.   

Abstract

Entities:  

Keywords:  ARSENICALS/therapeutic use; TRYPANOSOMIASIS, AFRICAN/therapy

Mesh：

Substances：

Year:  1957        PMID： 13409596     DOI： 10.1016/0035-9203(57)90010-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  3 in total

Review 1.  Chemotherapy for second-stage human African trypanosomiasis.

Authors:  Vittoria Lutje; Jorge Seixas; Adrian Kennedy
Journal:  Cochrane Database Syst Rev       Date:  2013-06-28

2.  The curative power of 4-(2:6-diaminopyrimidin-4-ylamino) phenylarsine oxide (compound 12,065) in infections of Trypanosoma rhodesiense in laboratory animals.

Authors:  J R BAKER
Journal:  Br J Pharmacol Chemother       Date:  1958-12

3.  Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage Rhodesiense sleeping sickness.

Authors:  Irene Kuepfer; Caecilia Schmid; Mpairwe Allan; Andrew Edielu; Emma P Haary; Abbas Kakembo; Stafford Kibona; Johannes Blum; Christian Burri
Journal:  PLoS Negl Trop Dis       Date:  2012-08-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.